Cite
Fingolimod therapy in early multiple sclerosis: an efficacy analysis of the TRANSFORMS and FREEDOMS studies by time since first symptom.
MLA
Agius, Mark, et al. “Fingolimod Therapy in Early Multiple Sclerosis: An Efficacy Analysis of the TRANSFORMS and FREEDOMS Studies by Time since First Symptom.” CNS Neuroscience & Therapeutics, vol. 20, no. 5, May 2014, pp. 446–51. EBSCOhost, https://doi.org/10.1111/cns.12235.
APA
Agius, M., Meng, X., Chin, P., Grinspan, A., & Hashmonay, R. (2014). Fingolimod therapy in early multiple sclerosis: an efficacy analysis of the TRANSFORMS and FREEDOMS studies by time since first symptom. CNS Neuroscience & Therapeutics, 20(5), 446–451. https://doi.org/10.1111/cns.12235
Chicago
Agius, Mark, Xiangyi Meng, Peter Chin, Augusto Grinspan, and Ronny Hashmonay. 2014. “Fingolimod Therapy in Early Multiple Sclerosis: An Efficacy Analysis of the TRANSFORMS and FREEDOMS Studies by Time since First Symptom.” CNS Neuroscience & Therapeutics 20 (5): 446–51. doi:10.1111/cns.12235.